June 2012
Diabetes Drug Could Increase Risk of Blindness
- Thu, 06/14/2012 - 10:56am
Statins may make you sleepy
- Tue, 06/12/2012 - 3:11pm
A recent randomized study revealed general fatigue and lack of energy during exercise as possible adverse side effects of statins in patients looking to reduce cholesterol.
Johnson & Johnson's type 2 diabetes drug trumps Januvia
- Mon, 06/11/2012 - 3:53pm
According to data from five late stage clinical studies, Johnson & Johnson’s new anti-diabetic drug canagliflozin decreased blood sugar by a significant amount when compared to alternative trea
FDA approves breakthrough breast cancer drug
- Mon, 06/11/2012 - 2:57pm
In an unprecedented breakthrough in breast cancer research, the FDA approved a new drug that should improve on the treatment of one of the most deadly forms of breast cancer to date, HER2-positive.
Metal-on-metal hip replacements may cause more pseudotumors
- Fri, 06/08/2012 - 1:39pm
Dutch researchers recently revealed that patients with metal-on-metal total hip replacement systems may be at a 10 percent greater risk for developing pseudotumors.
Study compares dabigatran to warfarin in treating blood clots
- Fri, 06/08/2012 - 12:31pm
A study headed by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy twice daily
Canadian study shows Actos doubles bladder cancer risk
- Fri, 06/08/2012 - 11:43am
Actos (pioglitazone) may double the risk for bladder cancer when taken for two years or more suggests a new Canadian study published in th
Bisphosphonate drugs may not lower cancer risk
- Thu, 06/07/2012 - 2:47pm
A new study shows that bisphosphonate drugs like Fosamax may not lower the risk for colon cancer despite what previous studies have
Pradaxa ranks first among drugs most often reported to the FDA
- Thu, 06/07/2012 - 10:27am
The Institute for Safe Medication Practices listed Pradaxa (dabigatran) as the drug most commonly reported to the U.S.
